Lee Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Lee Financial’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15	Closed	-$1K	–	989
2021 Q4	$1K	Buy	+15	New	+$917	﹤0.01%	886

Other funds holding AXNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lee Financial's AXNX Position: Q1 2022 in Review

Lee Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2022, closing a stake of 15 shares — an estimated $1K sold.

Lee Financial first reported a position in AXNX in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 186 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

Lee Financial reported no remaining Axonics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Lee Financial sold 15 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $1K.
Lee Financial first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
Lee Financial's Axonics, Inc. Common Stock position peaked at $1K in Q4 2021.
186 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Lee Financial's 13F filing for Q1 2022, filed 11 May 2022.